Corsair Pharma Announces $23 Million Series B Financing To Advance Clinical Trials In Pulmonary Arterial Hypertension
Amount Raised
$23 Million
Round Type
Series B
MilpitasManufacturingGamingPharmaceuticalDescription
Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced the closing of its $23M Series B financing led by New Rhein Healthcare Investors. Proceeds from the financing will support the clinical advancement of Corsair’s lead product candidate, a prodrug of treprostinil delivered in a proprietary transdermal patch to treat Pulmonary Arterial Hypertension (PAH). Wedbush PacGrow functioned as a financial advisor to Corsair Pharma for the Series B financing. Junson Capital, Primavera Capital, Plaisance Capital and Midas Capital joined New Rhein as co-investors in this financing.
Quick answer
Corsair raised $23 Million in a Series B round, dated September 20, 2023. Corsair is based in Milpitas, California, United States.
- How much did Corsair raise?
- Corsair raised $23 Million in a Series B round on September 20, 2023.
- What does Corsair do?
- Corsair is a global specialist investment firm offering opportunities for investors and solutions for companies across financial & business services and infrastructure.
- Where is Corsair based and how big is it?
- Corsair is based in Milpitas, California, United States. Fundz records about 1,328 employees.
- Who are the decision-makers at Corsair?
- Fundz holds 3 contacts at Corsair, including the Chief Information Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Gaming and Pharmaceutical around the same time
Companies in the same sectors as Corsair that raised within 45 days of this round, from Fundz verified event records.
- Triastek raised $20M (Funding Round) on September 28, 2023.
- Scinai Immunotherapeutics Ltd raised $1.3M (Seed) on September 19, 2023.
- Workers First raised $50K (Pre-Seed) on November 3, 2023.
- Talus Renewables raised $22M (Series A) on November 2, 2023.
- Genezen raised $19M (Private Equity) on November 2, 2023.
- HeartBeat.bio raised $4.8M (Seed) on November 2, 2023.
Who to call at Corsair, and when
A new round usually means Corsair is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Corsair raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Corsair, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Corsair. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Corsair raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCorsair raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.